The title of this metabolomic study “Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” made it clear that something new was in the works. Peroxisomal dysfunction had...
“Millions of people continue to suffer from exhaustion, cognitive problems and other long-lasting symptoms after a coronavirus infection. The exact causes of the illness, known as long Covid, are not known. But new research offers clues, describing the toll the...
The Norwegians are doing it again – reminding us that the fight to understand ME/CFS/FM is an international effort and that crucial insights are coming in from across the globe. The Norwegian odyssey has been interesting. Fluge and Mella began with an...
It didn’t take David Systrom long to take on long COVID. Systrom – the Harvard pulmonologist whose invasive exercise tests are redefining how we think about chronic fatigue syndrome (ME/CFS) – didn’t lead this study but helped design, analyze...
I have a feeling that interesting treatment trials for long COVID may become a regular blog topic on Health Rising. That would be a nice change. Treatment trials have been chronic fatigue syndrome’s Achilles heel. Except for cognitive behavioral therapy (CBT)...
Chris Armstrong PhD (biochemistry and molecular biology) was there at the beginning of the metabolomics field in chronic fatigue syndrome (ME/CFS). In fact, Armstrong was the lead author of the first ME/CFS metabolomics study published in 2012. I asked him how he got...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.